+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study



Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study



Bmc Medical Genetics 14: 19



The microsomal triglyceride transfer protein (MTTP) is encoded by the MTTP gene that is regulated by cholesterol in humans. Previous studies investigating the effect of MTTP on ischemic heart disease have produced inconsistent results. Therefore, we have tested the hypothesis that the rare allele of the -164T > C polymorphism in MTTP alters the risk of cardiovascular disease (CVD), depending on the cholesterol levels. The -164T > C polymorphism was genotyped in a case-cohort study (193 incident myocardial infarction (MI) and 131 incident ischemic stroke (IS) cases and 1 978 non-cases) nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study, comprising 27 548 middle-aged subjects. The Heinz Nixdorf Recall study (30 CVD cases and 1 188 controls) was used to replicate our findings. Genotype frequencies were not different between CVD and CVD free subjects (P = 0.79). We observed an interaction between the -164T > C polymorphism and total cholesterol levels in relation to future CVD. Corresponding stratified analyses showed a significant increased risk of CVD (HR(additve) = 1.38, 95% CI: 1.07 to 1.78) for individuals with cholesterol levels <200 mg/dL in the EPIC-Potsdam study. HR(additive) was 1.06, 95% CI: 0.33 to 3.40 for individuals in the Heinz Nixdorf Recall study. A borderline significant decrease in CVD risk was observed in subjects with cholesterol levels ≥ 200 mg/dL (HR(additve) = 0.77, 95% CI: 0.58 to 1.03) in the EPIC-Potsdam study. A similar trend was observed in the independent cohort (HR(additve) = 0.60, 95% CI: 0.29 to 1.25). Our study suggests an interaction between MTTP -164T > C functional polymorphism with total cholesterol levels. Thereby risk allele carriers with low cholesterol levels may be predisposed to an increased risk of developing CVD, which seems to be abolished among risk allele carriers with high cholesterol levels.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054379535

Download citation: RISBibTeXText

PMID: 23356586

DOI: 10.1186/1471-2350-14-19


Related references

Microsomal triglyceride transfer protein -164 T?gt;?C gene polymorphism and risk of cardiovascular disease results from the EPIC-Potsdam case-cohort study. 2013

Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young african american men: results from the coronary artery risk development in young adults (CARDIA) study. Arteriosclerosis, Thrombosis, and Vascular Biology 20(5): 1316-1322, 2000

Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study. European Journal of Epidemiology 30(2): 131-141, 2015

Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study. Atherosclerosis 251: 415-421, 2016

Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort - role of fat assimilation. Molecular Nutrition and Food Research 51(2): 185-191, 2007

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 109(19): 2279-2284, 2004

Influence of microsomal triglyceride transfer protein-493G/T polymorphism on cardiovascular events after myocardial infarction in diabetic patients. Journal of the American College of Cardiology 43(5 Suppl. A): 299A, 2004

Functional studies of a common promoter polymorphism in the microsomal triglyceride transfer protein gene. Circulation 100(18 Suppl. ): I 197, 1999

Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. International Journal of Molecular Medicine 17(1): 83-88, 2006

Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients. Molecular Genetics and Metabolism 88(2): 196-198, 2006

Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arteriosclerosis Thrombosis and Vascular Biology 22(2): 289-293, 2002

The relation between dietary protein, calcium and bone health in women: results from the EPIC-Potsdam cohort. Annals of Nutrition and Metabolism 49(5): 312-318, 2005

Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein. Metabolism: Clinical and Experimental 58(9): 1306-1311, 2009

A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arteriosclerosis Thrombosis and Vascular Biology 18(5): 756-761, 1998

Effect of microsomal triglyceride transfer protein gene polymorphism in the promoter region on dyslipidemia in type 2 diabetic subjects. Chinese Medical Journal 116(2): 215-217, 2003